Document is current
Any future updates will be listed below
-
Authors
Huelse, Justus M. https://orcid.org/0000-0002-1541-1617
Bhasin, Swati S. https://orcid.org/0000-0001-8661-1459
Jacobsen, Kristen M.
Yim, Juhye https://orcid.org/0000-0002-6949-9669
Thomas, Beena E.
Branella, Gianna M.
Bakhtiari, Mojtaba
Chimenti, Madison L.
Baxter, Travon A.
Raikar, Sunil S. https://orcid.org/0000-0003-2903-9542
Wang, Xiaodong
Frye, Stephen V. https://orcid.org/0000-0002-2415-2215
Henry, Curtis J.
Earp, H. Shelton
Bhasin, Manoj
DeRyckere, Deborah https://orcid.org/0000-0002-7457-9006
Graham, Douglas K. https://orcid.org/0000-0002-6201-6900
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA 249190-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01 CA 249190-01)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1 CA 205398)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 23 February 2023
Revised: 27 August 2024
Accepted: 4 September 2024
First Online: 25 September 2024
Competing interests
: DKG, SVF, and HSE are founders of Meryx Inc. and serve on the Scientific Advisory Board. DKG and SVF also serve on the Board of Directors of Meryx Inc. SVF, HSE, DKG, DD, and XW are equity holders in Meryx Inc. The company’s key clinical candidate, MRX-2843, is evaluated in this research. XW and SVF are inventors on patents describing MRX-2843 (patent numbers listed in Supplemental Materials). MB is founder and equity holder in Canomiks Inc. SSB and MB are founders and equity holders in Anxomics LLC.
